Eli Lilly Loses Appeal Over Medicaid Drug Pricing Fraud Case

benzinga.com/news/legal/25/09/47649878/eli-lilly-loses-appeal-over-medicaid-drug-pricing-fraud-case

A federal appeals court has upheld a $183.7 million judgment against Eli Lilly and Co. (NYSE:LLY), rejecting the drugmaker's attempt to overturn a whistleblower lawsuit that accused it of defrauding Medicaid.
Reuters reported that the ruling reinforces a jury's finding that Lilly…

This story appeared on benzinga.com, 2025-09-12 18:09:21.
The Entire Business World on a Single Page. Free to Use →